Millennium Management’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,068
| Closed | -$116K | – | 6016 |
|
|
2024
Q3 | $116K | Buy |
6,068
+3,209
| +112% | +$54.8K | ﹤0.01% | 5553 |
|
|
2024
Q2 | $55.8K | Sell |
2,859
-10,936
| -79% | -$211K | ﹤0.01% | 5401 |
|
|
2024
Q1 | $317K | Buy |
13,795
+11,552
| +515% | +$249K | ﹤0.01% | 5103 |
|
|
2023
Q4 | $39.4K | Buy |
+2,243
| New | +$32K | ﹤0.01% | 5521 |
|
|
2023
Q3 | – | Sell |
-2,220
| Closed | -$37.3K | – | 6178 |
|
|
2023
Q2 | $37.3K | Buy |
+2,220
| New | +$38.2K | ﹤0.01% | 5528 |
|
|
2023
Q1 | – | Sell |
-3,588
| Closed | -$60K | – | 6430 |
|
|
2022
Q4 | $60K | Sell |
3,588
-7,043
| -66% | -$127K | ﹤0.01% | 5730 |
|
|
2022
Q3 | $180K | Sell |
10,631
-9,750
| -48% | -$214K | ﹤0.01% | 5711 |
|
|
2022
Q2 | $449K | Sell |
20,381
-50,347
| -71% | -$1.22M | ﹤0.01% | 5048 |
|
|
2022
Q1 | $2.43M | Buy |
70,728
+46,028
| +186% | +$1.38M | ﹤0.01% | 3691 |
|
|
2021
Q4 | $1.02M | Buy |
24,700
+7,002
| +40% | +$454K | ﹤0.01% | 4389 |
|
|
2021
Q3 | $1.59M | Buy |
17,698
+6,029
| +52% | +$532K | ﹤0.01% | 4164 |
|
|
2021
Q2 | $852K | Sell |
11,669
-756
| -6% | -$35.1K | ﹤0.01% | 4812 |
|
|
2021
Q1 | $460K | Buy |
12,425
+7,888
| +174% | +$396K | ﹤0.01% | 4893 |
|
|
2020
Q4 | $186K | Buy |
+4,537
| New | +$118K | ﹤0.01% | 4844 |
|
|
2020
Q3 | – | Sell |
-9,642
| Closed | -$272K | – | 4487 |
|
|
2020
Q2 | $272K | Buy |
9,642
+4,896
| +103% | +$144K | ﹤0.01% | 3712 |
|
|
2020
Q1 | $121K | Sell |
4,746
-11,991
| -72% | -$443K | ﹤0.01% | 3509 |
|
|
2019
Q4 | $728K | Sell |
16,737
-1,965
| -11% | -$41.3K | ﹤0.01% | 3155 |
|
|
2019
Q3 | $176K | Sell |
18,702
-14,286
| -43% | -$205K | ﹤0.01% | 3822 |
|
|
2019
Q2 | $481K | Buy |
+32,988
| New | +$588K | ﹤0.01% | 3264 |
|
|
2019
Q1 | – | Sell |
-36,525
| Closed | -$586K | – | 4011 |
|
|
2018
Q4 | $586K | Sell |
36,525
-23,437
| -39% | -$1.1M | ﹤0.01% | 2863 |
|
|
2018
Q3 | $5.53M | Sell |
59,962
-23,108
| -28% | -$2.75M | 0.01% | 1725 |
|
|
2018
Q2 | $13.3M | Sell |
83,070
-10,112
| -11% | -$1.7M | 0.02% | 1126 |
|
|
2018
Q1 | $15M | Buy |
93,182
+91,487
| +5,397% | +$11.1M | 0.02% | 1065 |
|
|
2017
Q4 | $178K | Buy |
+1,695
| New | +$182K | ﹤0.01% | 3559 |
|
|
2017
Q2 | – | Sell |
-1,365
| Closed | -$163K | – | 3502 |
|
|
2017
Q1 | $163K | Sell |
1,365
-18,083
| -93% | -$2.13M | ﹤0.01% | 3258 |
|
|
2016
Q4 | $2.61M | Buy |
+19,448
| New | +$4.88M | 0.01% | 1730 |
|
|
2016
Q3 | – | Sell |
-4,610
| Closed | -$485K | – | 3292 |
|
|
2016
Q2 | $485K | Buy |
+4,610
| New | +$483K | ﹤0.01% | 2506 |
|
Other funds holding CLSD
CG
BCM
Millennium Management's CLSD Position: Q4 2024 in Review
Millennium Management sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 6,068 shares — an estimated $116K sold.
Millennium Management first reported a position in CLSD in Q2 2016 and held it in 27 quarters. The position peaked at $15M in Q1 2018. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.
- Millennium Management reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
- Millennium Management sold 6,068 Clearside Biomedical shares in Q4 2024, an estimated $116K.
- Millennium Management first reported a position in Clearside Biomedical in Q2 2016 and held it in 27 quarters.
- Millennium Management's Clearside Biomedical position peaked at $15M in Q1 2018.
- 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.
Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.